Literature DB >> 22832157

Elevated serum IL-6, IL-8, MCP-1, CRP, and IFN-γ levels in 10- to 11-year-old boys with increased BMI.

L Utsal1, V Tillmann, M Zilmer, J Mäestu, P Purge, J Jürimäe, M Saar, E Lätt, K Maasalu, T Jürimäe.   

Abstract

BACKGROUND/AIMS: Many inflammation parameters are associated with obesity, but few comparable data are found in youth. This study aims to characterize the differences in serum levels of 13 biochemical inflammatory markers between boys with increased BMI and boys with normal BMI, and examine the relationships between inflammation markers, skinfold thicknesses, and body composition. PARTICIPANTS/
METHODS: The participants were 38 boys (BMI above 85th percentile) and 38 boys (normal BMI) at the age of 10-11 years. Measurements included BMI, 9 skinfold thicknesses, waist and hip circumferences, and total body and trunk fat mass and percentage as indices of obesity, fasting insulin, glucose, and serum concentrations of IL-2, IL-4, IL-6, IL-8, IL-10, VEGF, IFN-γ, TNF-α, IL-1α, IL-1β, monocyte chemoattractant protein-1 (MCP-1), epidermal growth factor, and CRP.
RESULTS: Overweight boys (OWB) were taller and more frequently in puberty than normal-weight boys (NWB). Skinfold thicknesses and body composition parameters were higher in OWB. They had significantly higher serum IL-6, IL-8, IFN-γ, MCP-1, and CRP values compared to NWB.
CONCLUSIONS: Six of 13 measured biochemical markers were significantly increased in OWB, indicating that many low-grade inflammatory processes are already involved in the development of obesity in childhood.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832157     DOI: 10.1159/000339831

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  21 in total

Review 1.  Metabolic basis of ethnic differences in diabetes risk in overweight and obese youth.

Authors:  Tanya L Alderete; Claudia M Toledo-Corral; Michael I Goran
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

2.  Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus.

Authors:  Ping Chen; Thuy Vu; Adimoolam Narayanan; Winnie Sohn; Jin Wang; Michael Boedigheimer; Andrew A Welcher; Barbara Sullivan; David A Martin; Juan Jose Perez Ruixo; Peiming Ma
Journal:  Pharm Res       Date:  2014-09-12       Impact factor: 4.200

3.  Serum interferon gamma concentration is associated with bone mineral density in overweight boys.

Authors:  L Utsal; V Tillmann; M Zilmer; J Mäestu; P Purge; M Saar; E Lätt; T Jürimäe; K Maasalu; J Jürimäe
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Bone Density in the Obese Child: Clinical Considerations and Diagnostic Challenges.

Authors:  Jennifer C Kelley; Nicola Crabtree; Babette S Zemel
Journal:  Calcif Tissue Int       Date:  2017-01-20       Impact factor: 4.333

Review 5.  Immunometabolism in obese asthmatics: are we there yet?

Authors:  Hashim A Periyalil; Peter G Gibson; Lisa G Wood
Journal:  Nutrients       Date:  2013-09-10       Impact factor: 5.717

6.  Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity.

Authors:  Chi-Jen Chang; Deng-Yuan Jian; Ming-Wei Lin; Jun-Zhi Zhao; Low-Tone Ho; Chi-Chang Juan
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 7.  Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity.

Authors:  Allyson K Palmer; Tamara Tchkonia; Nathan K LeBrasseur; Eduardo N Chini; Ming Xu; James L Kirkland
Journal:  Diabetes       Date:  2015-07       Impact factor: 9.461

8.  Pubertal Physical Activity and Cardiorespiratory Fitness in Relation to Late Adolescent Body Fatness in Boys: A 6-Year Follow-Up Study.

Authors:  Liina Remmel; Reeli Tamme; Vallo Tillmann; Evelin Mäestu; Priit Purge; Eva Mengel; Eva-Maria Riso; Jaak Jürimäe
Journal:  Int J Environ Res Public Health       Date:  2021-05-03       Impact factor: 3.390

9.  Analysis of inflammatory mediators in type 2 diabetes patients.

Authors:  Ahmed Al-Shukaili; Saif Al-Ghafri; Safia Al-Marhoobi; Said Al-Abri; Jawad Al-Lawati; Masoud Al-Maskari
Journal:  Int J Endocrinol       Date:  2013-05-20       Impact factor: 3.257

10.  Class II transactivator (CIITA) mediates transcriptional repression of pdk4 gene by interacting with hypermethylated in cancer 1 (HIC1).

Authors:  Mingming Fang; Ping Li; Xiaoyan Wu; Yong Xu
Journal:  J Biomed Res       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.